Fight Fingers FIGHT FINGERS

Mobile Splinting Devices for Finger Injury & Grip Support

Seed Deck Addendum

Seed Deck Addendum

A0 Glossary (Terms & Acronyms)

ADCC — Abu Dhabi Combat Club hosts the Submission Fighting World Championship, one of the most prestigious No-Gi grappling tournaments.

ACV (Annual Contract Value) — Annualized value of a B2B account/contract; e.g., $1k–$10k+ per account.

AD (Athletic Director) — School administrator overseeing athletics; buyer/approver in Contact Sports.

ANZ — Australia & New Zealand; priority international markets in Horizon 3.

AOV (Average Order Value) — Average dollar amount per transaction; D2C AOV $24–$48.

ARPU (Average Revenue per User) — Per-athlete annual plan revenue; deck anchor ≈ $95.

AT (Athletic Trainer) — Licensed sports-medicine professional and key specifier in schools/clubs.

B2B (Business-to-Business) — Institutional/organizational sales (gyms, teams, Military & Tactical).

BJJ (Brazilian Jiu-Jitsu) — Core combat-sport cohort for launch.

BLS (Bureau of Labor Statistics) — Source for athletic-trainer employment growth used in Tailwinds.

Buddy Taping — Mobile splinting where an injured finger is taped to an adjacent healthy finger for stability.

CAC (Customer Acquisition Cost) — Spend to acquire a customer/account; target payback ≤ 6 months.

CAGR (Compound Annual Growth Rate) — Protective-equipment market growth (~5–6% this decade).

CIF (California Interscholastic Federation) — State body cited for girls' flag football data.

CO (Commanding Officer) — Unit leader endorsement in Military & Tactical pilots.

COGS (Cost of Goods Sold) — Basis for gross margin; improved via tooling/packaging/3PL.

COI (Certificate of Insurance) — Vendor onboarding document noted in Contact Sports mitigants.

CPG (Consumer Packaged Goods) — Products sold quickly at relatively low cost via retail or e-commerce.

CPG-Health — CPG focused on health; potential acquirer class for platform expansion.

CPT / HCPCS — Procedure/coding pathways noted in Med-Tech exploration.

DME (Durable Medical Equipment) — Clinic/coverage context referenced in Med-Tech pathway.

DoD (U.S. Department of Defense) — Source for O&M budget/tailwind; Military & Tactical buyer.

D2C (Direct-to-Consumer) — Core early channel; part of staged go-to-market.

DIP (Distal Interphalangeal Joint) — Outermost finger joint, often affected by fingertip and tendon injuries.

EV / Revenue Multiple — Valuation shorthand for payoff path ranges (e.g., ~4–6× early, ~7–12× at scale).

EU (European Union) — Priority international market in Horizon 3.

FX (Foreign Exchange) — Modeled neutral through Year 2 in financial inputs.

G&A (General & Administrative) — Operating expense category with efficiency target < 8% by Year 5.

GM (Gross Margin) — Target ~68–70% steady-state; minimum ≥ 60% for tranche gates.

GSA (U.S. General Services Administration) — Federal contract vehicle for Military & Tactical channel.

GTM (Go-to-Market) — Commercialization roadmap (channels, ambassadors, retail, procurement).

IBISWorld — Market research source for studio/venue growth.

IBJJF — International Brazilian Jiu Jitsu Federation; hosts major tournaments worldwide.

IP (Intellectual Property) — Valuation driver at scale and risk/mitigants area.

KOL (Key Opinion Leader) — Athlete/coach influencers who drive adoption, especially in Combat Sports.

KPI (Key Performance Indicator) — Operating proof points (e.g., sell-through turns, renewal).

LEO (Law Enforcement Officer) — Included in Military & Tactical cohort definition.

LTV (Customer Lifetime Value) — Paired with CAC; target LTV/CAC ≥ 3×.

MMA (Mixed Martial Arts) — Multidisciplinary, core combat cohort/sport.

Mobile Splinting — Recovery method allowing limited motion in injured joints to promote healing without immobilization.

MOU (Memorandum of Understanding) — Used for pilot success metrics in Military & Tactical mitigants.

NA (North America) — Launch market; projected to deliver ~85% of revenue through Year 3.

NAIA — Collegiate governing body; recognition of women's flag (invitational) used in Tailwinds.

NCAA / NFHS — U.S. college and high-school governing bodies cited for participation data.

Next-Gen Recovery Gear — New equipment category designed for performance demands and functional PAR.

NPS (Net Promoter Score) — Satisfaction/advocacy metric tracked in pilots.

NTM / TTM — "Next Twelve Months" / "Trailing Twelve Months," used in valuation notes.

O&M (Operations & Maintenance) — DoD budget area supporting training/equipment spend.

OEM (Original Equipment Manufacturer) — Company producing components or finished products rebranded for resale.

OPEX / OpEx (Operating Expenses) — Guardrails and mix targets in financial inputs.

OTC (Over-the-Counter) — Consumer-health channel; optional acquirer pathway.

OUSD (Office of the Under Secretary of Defense) — DoD source cited for tailwinds.

PAR (Post-Injury Active Recovery) — Category/approach: stabilize without immobilizing so athletes keep training while healing.

Penetration (Y5) — Disciplined, segment-specific adoption rate used to derive SOM by Year 5.

PIP (Proximal Interphalangeal Joint) — Middle finger joint; common site of sprains and dislocations.

Pool (Cohort) — Annual, de-duplicated participants/personnel in a segment's geography used for TAM/SAM/SOM math.

PO (Purchase Order) — Institution-friendly buying method referenced in Contact Sports pricing.

PT / OT (Physical/Occupational Therapy) — Clinical protocol bundling noted for Med-Tech.

SAM (Serviceable Addressable Market) — Reachable subset in plan × recovery-relevance × ARPU/ACV.

SKU (Stock Keeping Unit) — Product variants/extensions referenced in roadmap (wrists, knees).

SOM (Serviceable Obtainable Market) — Modeled Year-5 share of SAM (penetration × SAM).

SOP (Standard Operating Procedure) — Quick-start training documents for unit pilots.

TAM (Total Addressable Market) — Pool × recovery-relevance × ARPU/ACV.

3PL (Third-Party Logistics) — Outsourced logistics partner; margin lever via optimization.

WC (Working Capital) — Inventory/cash cycle efficiency; discussed in use-of-funds and value levers.

WHO / CDC — Health bodies cited for injury/epidemiology references.

Y1–Y5 — Year-1 to Year-5; used for revenue ramp and penetration modeling.

YoY (Year-over-Year) — Growth framing used in participation tailwinds and valuation targets.

A1 Sources & Method (Material References)
Participation & incidence: NFHS participation reports; NCAA Sports Sponsorship & Participation; peer-reviewed hand/finger injury studies (fracture and sprain/strain cohorts); WHO/CDC injury summaries; orthopedic compendia for return-to-sport ranges.
Category/market sizing: IBISWorld (martial arts/fitness studios; protective gear), Grand View Research (sports protective & recovery), Statista (retail/e-comm spend), public filings/press for comps (Hyperice, Therabody, WHOOP, Catapult, Garmin—directional).
Method: Pool × recovery-relevance × disciplined penetration × ARPU, de-duplicated across sports/roles. Recovery-relevance bands (≈15–30%) vary by segment. ARPU ≈ $95 (annual plan). B2B accounts priced by kit count/site.
Traceability: All slide claims footnoted to source and dated; see "Market Assumptions" table for cohort math and ties to TAM/SAM/SOM.
A2 Market Assumptions (Audit Table)

TAM–SAM–SOM inputs. SAM = Y5 Reachable (NA + selected international), harmonized with Market Segmentation slide

SegmentTarget Pool (Global)SAM PoolRecovery RelevancePenetrationARPU/ACVSOM (Y5)Channel
Combat Sports7.5–8.5M~5M25–30%3–5%~$95 ARPU$13–18MD2C, Retail, Ambassadors
Contact Sports16–18M~25M10–15%1–2%~$95 ARPU$10–15MInstitutions, Teams, Schools, Retail
Tactical / Military3.5–4M~3.5M10–15%1–3%$1k–10k+ ACV$4–8MUnit Kits, Procurement
International10–12M~10–12MSimilar0.5–1%~$95 / ACV$4–7MD2C, Institutions, Retail
Totals$31–48M

All pools de-duplicated; ARPU = $95 annual plan; B2B ACV priced by site/kit. Mid-case tie-out: ≈ $38M (matches Market Segmentation Slide)

Formulas (audit shorthand)

TAM = Global Pool × Recovery-Relevance × ARPU/ACV
SAM (Y5) = (SAM Pool Y5) × Recovery-Relevance
SOM (Y5) = SAM (Y5) × Penetration (Y5) × ARPU/ACV

Notes & Definitions

ARPU = Average Revenue per User (D2C/Retail)
ACV = Annual Contract Value (B2B/Institutional)
SAM Pool (Y5) = NA + selected international markets in current plan.
All cohorts are de-duplicated across segments.
Pricing basis = Combat/Contact use ARPU (~$95); Military & Tactical uses ACV ($1k–10k+); International uses ARPU for D2C/Retail and ACV where applicable.
A3 Revenue Growth

Disciplined Path to ~$38M Y5

Y1
$2M
Launch
Y2
$4.5M
+125%
Y3
$10M
+122%
Y4
$22M
+120%
Y5
$38M
+73%
Combat Sports Contact Sports Tactical / Military International
SegmentY1Y2Y3Y4Y5
Combat Sports$2.0M$4.0M$4.5M$8.0M$13M
Contact Sports$0.5M$3.5M$7.0M$11M
Tactical / Military$2.0M$4.0M$7M
International$3.0M$7M
Total$2M$4.5M$10M$22M$38M

Growth Drivers

Combat Sports adoption drives early traction.
Contact Sports volume expansion from Y2.
Tactical / Military adds high-value B2B revenue layer.
International adds diversification + scale from Y4.

Segmented pools + disciplined penetration = a clear path to ~$38M Y5.

A4 Segment Cohort Details

Purpose. Granular assumptions behind each segment used in Slide 4 and A2. Sources trace to A1 — Sources & Method. PAR = Post-Injury Active Recovery.

Combat Sports (BJJ, Wrestling, MMA gyms/dojos)

Cohort & pool: ~7.5–8.5M practitioners (BJJ/wrestling/MMA); concentrated in gyms/dojos with repeat weekly exposure.

Recovery-relevance: 25–35% annually (sprain/strain + prophylactic use) driven by grip-intensive training volume.

Decision makers: Head coaches/owners, program directors, pro-shop managers; KOL athletes.

Channels: DTC; dojo retail displays; affiliate/ambassador codes; select specialty retail.

Standardization triggers: Club bundle pricing; bulk coach packs; competition-legal design; visible pro/KOL adoption.

Pricing anchors: D2C AOV $24–$48 / ARPU $95 annual plan (gear + wear/tear + cleaner); volume discounts at 25/50/100 units.

Pilot criteria: ≥2 coaches signed; ≥50 athletes sampled; ≥70% keep rate after 30 days.

KPIs: Renewal rate; dojo attach rate; weekly reorder velocity; coach NPS.

Risks: Tape inertia; rule-set misconceptions; price sensitivity among casual users.

Mitigants: Legality sheet in kit; coach education videos; "first month on us" team trials.

Contact Sports (football, basketball, baseball, and other ball / team sports)

Cohort & pool: ~16–18M athletes (HS/college/club) with seasonal exposure and school budget cycles.

Recovery-relevance: 15–25% annually; finger/hand incidents + prevention during in-season practice.

Decision makers: Athletic Trainers (ATs), head coaches, ADs; district purchasing for multi-school buys.

Channels: School/club bulk orders; team packs via distributors; retail for parents.

Standardization triggers: AT protocol inclusion; pre-season kit lists; sample-to-standard program per school.

Pricing anchors: D2C AOV $24–$48 / ARPU $95; team packs (25/50/100) with AT spares; PO-friendly terms.

Pilot criteria: 3–5 teams per district; AT champion; injury-log trial with before/after survey.

KPIs: Team adoption %; AT reorder cadence; replenishment per roster; school-year retention.

Risks: Budget timing; vendor onboarding friction; compliance questions.

Mitigants: Bid-ready SKUs; W-9/COI packet; trainer education; district references.

Military & Tactical (U.S./Canada active duty, LEO, select federal)

Cohort & pool: ~3.5–4.0M personnel; training-intense tasks; centralized procurement.

Recovery-relevance: 10–20% accounts annually (duty-cycle finger stress + readiness mandates).

Decision makers: Unit trainers, medical/physio leads, supply NCOs; procurement officers.

Channels: Unit kits via procurement pilots; GSA/contract vehicles as available; tactical distributors.

Standardization triggers: Inclusion in unit training protocols; readiness-KPI link (reduced light-duty days).

Pricing anchors: ACV $1k–$10k+ per account (kit density × sites × replenishment).

Pilot criteria: 2–3 units; 90-day readiness pilot; usage + incident logs; Commanding Officer endorsement.

KPIs: Kits per unit; replenishment cycles; incident-day reduction (directional); expansion to adjacent units.

Risks: Contract lead times; product durability in field; documentation burden.

Mitigants: Ruggedization spec; quick-start SOP; pilot MOU with clear success metrics.

International Expansion (Brazil, Japan, EU, ANZ)

Cohort & pool: ~10–12M relevant participants; phased entry Y3–Y5 with partner focus.

Recovery-relevance: 15–25% annually; varies by sport mix and federation rules.

Decision makers: Gym owners, retailers, distributors; national team coaches; federation liaisons.

Channels: Distributor partnerships; marketplace/e-comm; select retail (category captains).

Standardization triggers: Federation rule confirmations; co-branded clinics; athlete/KOL localization.

Pricing anchors: D2C AOV $24–$48 / ARPU $95 (localized pricing bands); distributor margins standard by region.

Pilot criteria: 1–2 anchor distributors per country; 50–100-door seed; national KOL demo tour.

KPIs: Door count live; sell-through turns; local NPS; returns rate.

Risks: VAT/import friction; counterfeit; rule-set variance.

Mitigants: Localized packaging & claims; anti-counterfeit markers; federation advocacy.

Global notes (applies to all segments)

De-duplication: Pools are annual and de-duplicated across sports/roles.
Evidence path: Accumulating PAR outcomes (re-injury rate, days-lost) underpins Med-Tech & Ortho buyer interest.
Ops guardrails: GM target ≥60%; CAC payback ≤6 months; renewal ≥80% on plans.

Risks & Mitigants

RiskMitigation
Slower adoption in adjacent marketsMaintain phased rollouts with pilot validation before scale
Competitive IP challengeProvisional + utility patents filed early; ongoing IP monitoring
Manufacturing scale-up delaysDual-source suppliers; staged capacity investments
Working capital constraintsTight inventory management; milestone-based capital draws

These mitigations are designed to ensure operational readiness and protect value creation trajectory.

A5 Tailwinds: Participation & Specifier Trends (North America)

These trends lead to larger feeder pools + more on-site decision-makers. This means faster standardization and repeat purchasing for PAR (Post-Injury Active Recovery) solutions.

1. Girls' Flag Football — Crossing the chasm

  • Data: National HS participation ≈ 68–70k (2024–25); ~+60% YoY; ~1,000 additional schools. California ≈ 19.9k, +84% YoY.
  • Ecosystem signals: NAIA recognition (2025–26 invitational); NFL–Nike $5M program seeding; state media running Top-15 rankings.
  • Implication: Contact-adjacent growth expands PAR relevance and school/club safety budgets.
  • Sources: NFHS; CIF; NAIA; NFL/Nike program notes; state media.

2. Combat Sport venue growth

  • Data: U.S. martial-arts/BJJ/MMA studios industry has grown (sites & revenue) in recent years.
  • Implication: Denser distribution base for DTC + retail pilots; larger injury/prevention addressable pool.
  • Sources: IBISWorld (martial arts/fitness studios).

3. Specifier cohort expansion

  • Data: Athletic-trainer employment +11% (2024–34).
  • Implication: More professional gatekeepers to select, standardize, and replenish recovery solutions across HS/college.
  • Sources: U.S. Bureau of Labor Statistics.

4. Sustained Tactical readiness spend

  • Data: FY2025 DoD O&M request emphasizes training/equipment priorities.
  • Implication: Supports standardized unit-level recovery kits in Military & Tactical channels.
  • Sources: DoD, Office of the Under Secretary of Defense (Comptroller) materials.

5. Protective & Recovery spend trend

  • Data: Global sports protective-equipment market projected ~5–6% CAGR this decade.
  • Implication: Consistent category budget growth for prevention/recovery where we slot.
  • Sources: Market research (e.g., Grand View Research).
A6 Financial Model: Key Inputs & Assumptions
Pricing: AOV $24–$48 / ARPU $95 annual plan per athlete (gear + wear-and-tear replacements + cleaner).
B2B ACV: $1k–$10k+ per account (site count, kit density, service).
Channel mix ramp (Y1→Y3): DTC 80% → 55%, Retail/Teams 20% → 45%; international begins Y3.
Gross margin: ~68–70% steady-state (COGS declines via volume tooling, packaging, 3PL optimization).
CAC / payback: Paid + blended creator/affiliate; ≤6-month payback target; retention ≥80% on plan renewals.
Working capital: Inventory turns ≥4×/yr; returns rate ≤3%; warranty reserve 1–2% of COGS.
OpEx guardrails: Marketing ≤20% of revenue post-scale; G&A efficiency improves to <8% by Y5.
Break-even: ~20k units equivalent at GM ≥60% and OPEX run-rate per plan.
FX/tax: FX neutral through Y2; effective tax ~25% modeled from profitability.
Milestones (for tranche logic): GM ≥60%, CAC payback ≤6 mo., sell-through ≥2.0 turns/quarter, runway ≥10 mo.
A7 Investor Payoff Paths / Strategic Exits (expanded)

Deeper Dive Acquirer – Buyer Types & Appetites

Athletic Wear Leaders

Nike, Adidas, Under Armour, Lululemon; performance gear incl. Hyperice

Why they buy: Category creation + expansion into prevention/active-recovery.
What we bring: Defensible finger safety & PAR franchise; BJJ/MMA/climbing credibility; high-margin refills.
Value levers: Global doors & e-comm lift, co-brand capsules, retail end-caps/academies, athlete amplification.

Med-Tech / Sports Innovators

Arthrex, Enovis/DJO, Smith+Nephew, Össur

Why they buy: Extend continuum of care (prevent → rehab) via clinic/trainer channels.
What we bring: Standardized, trainer-ready kit for high-incidence digit injuries; outcomes data partnerships.
Value levers: PT/OT protocol bundling, team/league medical adoption; explore CPT/HCPCS pathways.

Performance Equipment Roll-ups: Health & Performance Gear players

Why they buy: Accretive add-on with clear whitespace and strong unit economics.
What we bring: Repeat behavior, DTC + retail mix, adjacent SKUs (grip/wrist/elbow).
Value levers: Sourcing & WC scale, multi-brand cross-sell, international rollout.
A8 Valuation Reference

Illustrative revenue multiples and maturity indicators

Early proof (~4–6× revenue): retail pilots live, ≥65–70% gross margin, early repeat-purchase signal, elite endorsements.
Scale (~7–12× revenue): multi-channel scale (pharmacy/mass, DTC, team/league), brand authority, outcomes/claims validation, issued/enforceable IP.

Footnote: Multiples refer to enterprise value as a multiple of next-twelve-months (NTM) revenue. Ranges are illustrative, not guidance. Actual outcomes vary with growth rate, margins, channel mix, and IP position.

A9 Key Value Drivers / Performance Targets & Comparable Transactions

To optimize valuation range, our job is to hit the operating proofs — category leadership first, optionality follows.

Performance targets designed to elevate valuation range:

60%+
Gross Margins
100%+
YoY, LTV / CAC ≥ 3× (within 6mo)
35–45%+
repeat/refill/renew rate

Signaling attractive market trajectory with proof of retail velocity and early clinical adoption.

Comparable Transactions

Selected comparable exits within sports, recovery technology, and performance gear sectors. These provide directional insight into potential valuation multiples.

CompanyAcquirerYearDeal ValueRev MultipleNotes
HypericePE Consortium2020$350M4–5xHigh growth recovery tech
WHOOPSoftBank (minority)2021$3.6B val.10–12xWearable recovery analytics
TherabodyPrivate investors2022$700M val.6–8xPercussive therapy devices
RockTapeImplus Corp2019~$50–70M est.3–4x est.Athletic taping products
KT TapePrivate investors2020$60–80M est.3–4x est.Elastic sports recovery tape
NormaTecHyperice2020~$20–30M est.3–4x est.Compression recovery

Sources: PitchBook, Crunchbase, press releases, industry analyst reports. Multiples are indicative estimates based on public disclosures and market norms for similar transactions.

These transactions are intended to be directional indicators only. They share characteristics in brand positioning, product innovation, IP defensibility, and addressable market that are in line with FF, illustrating a range of valuation multiples (revenue and EBITDA) that may inform exit expectations under different growth and profitability scenarios.

A10 Regulatory / Evidence Pathway (Med-Tech option)

Med-Tech option: DME, CPT/HCPCS, PT/AT protocols

A staged evidence + compliance plan expands permissible claims, unlocks AT/PT and clinic workflows, and builds strategic acquirer readiness—without slowing our current commercial plan.

1) Claims ladder (what we say grows with what we prove)

Phase 0: Consumer/Performance (now)

"Supports/stabilizes finger during activity," "reusable alternative to tape," "maintains mobility for training." (No disease or treatment claims.)

Phase 1: Practice/Protocol (near term)

"Enables Post-Injury Active Recovery (PAR) protocols that reduce missed training days vs tape-as-usual," "improves functional grip and training continuity in athletes with finger sprain/strain."

Phase 2: Clinical/Outcomes (optionality)

"In athletes with acute finger sprain/strain, PAR with Fight Fingers yielded faster return-to-train, lower reinjury, and better function (QuickDASH/grip) vs standard taping." (Advance only when supported.)

Claims hygiene: do / don't. Do: supports, stabilizes, helps maintain mobility, may reduce missed training days (per study). Don't (until supported/cleared): treats, heals, prevents fractures, disease-specific claims.

2) Evidence package (settings, designs, endpoints)

Settings. BJJ academies; HS/college programs (AT-led); climbing gyms; 1–2 Military & Tactical training units. Study designs (stacked, pragmatic).
Bench/Usability (Month 0–2): fit, durability, cleanability; basic biocompatibility screen on skin-contact materials.
Prospective Registry (Month 1–12): rolling cohort on a standardized PAR protocol; real-world outcomes and safety.
Pragmatic Comparative (Month 4–12): PAR vs tape-as-usual, cluster-randomized at dojo/team to reduce contamination.
PT/AT Protocol Pilot (Month 6–12): embed PAR in AT workflow at 2–3 schools; outcomes + economics.

3) Evidence Endpoints & Targeted Claims Metrics

Primary endpoints that unlock claims progression and Med-Tech acquirer interest:

Endpoint / MetricMeasurementClaims Unlock
Return-to-Train (RTT)Days from injury to full practice"Reduces missed training days"
Return-to-Play (RTP)Days from injury to competition"Supports faster return to competition"
Reinjury Rate% reinjury at 8–12 weeks"Lower reinjury vs tape-as-usual"
QuickDASH ScoreValidated upper-extremity function"Improved functional outcomes"
Grip DynamometerObjective grip strength (kg)"Supports grip recovery"
Pain (NPRS)Numeric Pain Rating Scale 0–10"Supports comfort during activity"
Tape DisplacementRolls/athlete/season replaced"Reduces tape waste & cost"
Cost per AthleteTotal kit cost / athlete / season"Economical protocol adoption"

4) Regulatory posture (right-sized today, expandable later)

Classification hypothesis: non-powered orthopedic support/splint (low-risk class, often 510(k)-exempt). Validate early with regulatory counsel. Near-term posture: commercialize under consumer/performance claims with labeling discipline, quality-minded manufacturing, and a materials file. If claims escalate: stand up QMS-lite aligned to ISO 13485; risk (ISO 14971); usability (IEC 62366); biocompatibility (ISO 10993 screen); UDI/labeling; basic post-market surveillance.

5) Coding & reimbursement (DMEPOS + services)

CategoryCode FamilyApplication
DeviceHCPCS Level II (L-codes)Hand/finger orthosis L-code families (e.g., L3900–L3999) or analogous DMEPOS codes for clinic/AT stock SKU if pursued.
SuppliesHCPCS A-codesCleaners/consumables could map to A-codes if clinic supply path chosen; otherwise retail/cash.
ServicesCPT (PT/OT/AT visits)Existing therapy/orthotic management codes; our contribution = protocol + device inside those visits, not a new CPT.

Near-term reality: cash-pay, retail, school POs, HSA/FSA—then selective clinic stock once protocols/evidence are published. (Confirm code selection with a reimbursement specialist before any payer statements.)

6) PT/AT protocol integration (the playbook)

PAR protocol: assessment → sizing → supervised first use → progression (ranges, reps, grips) → return-to-train decision aid.

Trainer tools: quick-start card, cleaning SOP, contraindications checklist, QR video library.

Docs & templates: injury log, adherence checklist, QuickDASH/pain before/after, reinjury/incident log.

Site success KPIs: ≥70% adherence, ≥30% reduction in missed training days, ≥25% reduction in tape usage.

7) 12-month workplan & budget bands (order-of-magnitude)

QuarterActivitiesBudget
Q1Finalize claims & labeling; vendor/materials file; bench/usability; launch registry at 2–3 anchors$25–60k
Q2Expand to 6–10 sites; start pragmatic comparative; publish protocol online$60–120k
Q3Interim read-out (n≈150–250); AT protocol pilot (2–3 schools); start reimbursement scoping$50–100k
Q4Pooled analysis + white paper; conference poster; go/no-go on coded clinic SKU$40–80k
TotalInternal + contractors + modest site honoraria/equipment grants$175–360k

Dependencies/assumptions. Access to anchor sites; consistent AT participation; legal review cadence for claims copy.

8) Risks & mitigations

RiskMitigation
Claims creepCentralized copy review; "green/yellow/red" claims list; versioned IFU
Underpowered dataPragmatic designs; rolling enrollment; pre-registered endpoints
AT/coach adoption stallsLead with time-savings & tape-budget wins; easy kit management
Biocompatibility complaintVerified materials file; skin-check guidance; rapid CAPA process

9) Exit relevance (why this raises strategic appetite)

Sports Recovery/Performance brands: category proof + protocol standardization = near-term stack fit.
Med-Tech & Ortho: outcomes + protocols + QMS-lite = diligence-ready asset with a line into DMEPOS/clinic workflows.
Consumer Health/OTC: credible outcomes → permission to claim "active recovery" at retail.

10) Clinical Pathway

Clinical Trials → Data → Data-Backed Claims → DME — Durable Medical Equipment Classification → FDA Class II Claims Approval → Code Assignment:

  • Diagnosis (ICD-10): S63.6XX — sprain of finger joint / ligament
  • Coverage Policy (LCD / NCD): Medicare coverage policy
  • Device (HCPCS): L3924 — hand / finger orthosis, prefabricated, off-the-shelf
  • Procedure (CPT): 29131 — application of finger splint; dynamic + 97760 — orthotic(s) management and training, initial encounter (assessment / fitting)

Targeted Claims Metrics:

  • Faster functional recovery
  • Improved performance during healing (grip strength, mobility, dexterity, QuickDASH)
  • Reduced reinjury rates
  • Higher comfort, convenience, & compliance driving higher protocol adherence = better outcomes

Path Summary

Consumer claims (now) → Protocol outcomes (12 mo) → Optional clinic/DME SKU (18–24 mo).

Proof: ↓ missed training days, ↓ reinjury, ↑ QuickDASH/grip, ↓ tape cost.
Compliance: claims hygiene, labeling/QMS-lite, materials file; escalate with counsel.
Payoff: opens PT/AT standardization and future reimbursement; increases Med-Tech/Ortho buyer interest.
A11 PIP Injury Spectrum & Clinical Context

Finger injuries, particularly to the middle knuckle (PIP - proximal interphalangeal joint), are high frequency, impacting one of the most crucial joints for functional gripping and hand strength.

PIP InjuryGrade I – Mild Sprain / Jammed FingerGrade II – Moderate Sprain / Partial TearGrade III – Complete Tear / Capsular Injury
DescriptionMicro-tears of collateral ligaments / volar platePartial tear of ligaments / volar plate; moderate instabilityFull ligament / volar plate rupture; severe instability / dislocation
PresentationPain, swelling, ROM (range of motion) lossPain, swelling, ROM & grip lossSevere pain, deformity, extreme loss of ROM, strength, functionality
InterventionBuddy tape, mobile splinting for early motionEarly immobilization, buddy tape for controlled mobilizationOrtho eval, potential surgery, immobilization, mobile splinting for ROM & strength restoration
Prognosis2–4 wks functional recovery
4–6 wks full recovery
2–4 wks initial healing
4–8 wks functional
8–12 wks full recovery
3–6 wks immobilization
6–12 wks early mobilization
3–6 mo functional
6–12 mo full recovery
A12 Injury Lifecycle & Adoption

Recovery requires supported mobility to restore strength, range of motion, and function.

Fight Fingers fits seamlessly into this continuum—an upgrade from buddy taping to purpose-built mobile splinting gear that delivers greater comfort, convenience, and superior hand performance during post-injury active recovery.

PIP InjuryGrade I – Mild
4–6 Week Recovery
Grade II – Moderate
8–12 Week Recovery
Grade III – Complete
6–12 Month Recovery
Stage 1Injury occursInjury occursInjury occurs
Stage 2Fight Fingers for Supported MobilitySplinting for ImmobilizationSurgical Intervention (if needed)
Stage 3ROM RehabilitationFight Fingers for Supported MobilitySplinting for Immobilization
Stage 4Healthy FingersROM RehabilitationFight Fingers for Supported Mobility
Stage 5Healthy FingersROM Rehabilitation
Stage 6Healthy Fingers